Gaorong Capital logo

Gaorong Capital

Asia, Beijing, China, Wangjing

Description

Gaorong Capital, established in 2014 by industry veterans Zhang Zhen, Gao Xiang, and Li Haifeng, stands as a prominent venture capital firm headquartered in Wangjing, China. The firm has rapidly grown to become a significant player in the Chinese investment landscape, primarily focusing on early and growth stage opportunities. Its investment mandate broadly covers the TMT (Technology, Media, and Telecommunications) sector, with a particular emphasis on emerging areas such as artificial intelligence, frontier technologies, enterprise services, and consumer-related innovations.

Gaorong Capital employs a strategy centered on identifying and nurturing high-potential companies that are poised for significant disruption and growth within their respective markets. The firm is known for its hands-on approach, providing not just capital but also strategic guidance and operational support to its portfolio companies. This comprehensive support system aims to accelerate the development of startups from their nascent stages through to market leadership. Their investment philosophy often involves backing visionary founders with strong execution capabilities, aiming for long-term value creation.

Since its inception, Gaorong Capital has demonstrated substantial scale and impact. The firm manages over $3 billion in assets under management across multiple funds, reflecting its robust fundraising capabilities and investor confidence. This capital has enabled Gaorong to make over 200 investments in a diverse range of companies, many of which have gone on to achieve significant valuations and market presence. For instance, in 2021, the firm successfully closed its fifth USD-denominated fund at $850 million, further solidifying its capacity to deploy substantial capital into promising ventures. Their portfolio includes several unicorns and publicly listed companies, underscoring their track record of identifying and supporting successful enterprises across various economic cycles.

Investor Profile

Gaorong Capital has backed more than 66 startups, with 12 new investments in the last 12 months alone. The firm has led 13 rounds, about 20% of its total and boasts 22 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series A, Series C rounds (top funding stages).
  • Majority of deals are located in China, United States, Singapore.
  • Strong thematic focus on Artificial Intelligence (AI), Biotechnology, Software.
  • Led 1 rounds in the past year.
  • Typical check size: $2M – $50M.

Stage Focus

  • Series B (30%)
  • Series A (27%)
  • Series C (20%)
  • Seed (9%)
  • Series Unknown (8%)
  • Series D (5%)
  • Angel (2%)

Country Focus

  • China (70%)
  • United States (14%)
  • Singapore (8%)
  • Ireland (3%)
  • United Kingdom (2%)
  • Nigeria (2%)
  • Australia (2%)
  • Hong Kong (2%)

Industry Focus

  • Artificial Intelligence (Ai)
  • Biotechnology
  • Software
  • Medical
  • Information Technology
  • Health Care
  • Financial Services
  • Internet
  • Real Estate
  • E-commerce
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Gaorong Capital frequently co-invest with?

Shunwei Capital
Asia, Beijing, China, Beijing
Co-Investments: 5
IDG Capital
Asia, Beijing, China, Beijing
Co-Investments: 7
Tencent
Asia, Guangdong, China, Shenzhen
Co-Investments: 5
Vision Plus Capital
Asia, Zhejiang, China, Hangzhou
Co-Investments: 4
GSR Ventures
North America, California, United States, Menlo Park
Co-Investments: 10
Capital Today
Asia, Shanghai, China, Shanghai
Co-Investments: 4
5Y Capital
Asia, Shanghai, China, Xuhui
Co-Investments: 7
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 11
Tiger Global Management
North America, New York, United States, New York
Co-Investments: 4
GGV Capital
North America, California, United States, Menlo Park
Co-Investments: 8

Which angels does Gaorong Capital often collaborate with?

Xiaoguang Wu
Asia, Guangdong, China, Shenzhen
Shared Deals: 1
YM
North America, California, United States, Los Altos Hills
Shared Deals: 1
KA
North America, California, United States, San Francisco
Shared Deals: 1
FE
North America, California, United States, San Francisco
Shared Deals: 1
BK
North America, California, United States, San Francisco
Shared Deals: 1

What are some of recent deals done by Gaorong Capital?

Wallaby Medical

Laguna Hills, California, United States

Wallaby Medical is a manufacturing company that produces avenir coil system and medical devices for stroke treatment.

ManufacturingMedicalMedical DeviceTherapeutics
Series CMar 17, 2026
HT Aero

Tianhe, Hubei, China

HT Aero aspires to be the pioneer of urban air mobility (UAM) and is dedicated to producing safe and intelligent electric flying vehicles.

AerospaceAutomotiveDronesElectric VehicleIntelligent Systems
Series UnknownMar 13, 2026
Amount Raised: $200,000,000
Zhijian Power

Hangzhou, Zhejiang, China

Zhijian Power is a high-tech enterprise specializing in the research and development of intelligent driving technology.

Artificial Intelligence (AI)AutomotiveSaaS
Series AMar 9, 2026
Immunofoco

Shanghai, Shanghai, China

Immunofoco is a biotechnology company that specializes in immune cell drugs for solid tumors patients.

BiotechnologyMedicalPharmaceutical
Series UnknownMar 3, 2026
Amount Raised: $29,071,880
KargoBot

Beijing, Beijing, China

KargoBot is a technology company that develops and deploys autonomous freight transport systems for logistics and cargo movement.

Artificial Intelligence (AI)AutomotiveFreight ServiceLogisticsTransportation
Series BMar 2, 2026
Amount Raised: $100,000,000
Cascade

Shanhai, Shanghai, China

Cascade produces novel medications that target nuclear receptors for treating metabolic disorders and inflammation.

BiopharmaBiotechnologyHealth CareMedical
Series UnknownFeb 10, 2026
Amount Raised: $72,349,477
Waffo

Hong Kong, Hong Kong Island, Hong Kong

Waffo a global payments platform provider supporting over 70 currencies and 300 payment methods.

Artificial Intelligence (AI)Financial ServicesGaming
Series AFeb 4, 2026
Amount Raised: $15,000,000
Sunrise

Hangzhou, Zhejiang, China

Sunrise is a metering solution provider that offers smart charging opertaions, water meter, and AMI solutions.

Charging InfrastructureElectrical DistributionEnergy ManagementManufacturing
Series UnknownJan 22, 2026
Amount Raised: $430,193,874

Taiyu New Materials specializes in the development and use of graphene surface technology.

Advanced Materials
Series AJan 21, 2026
Kind Pharmaceutical

Hangzhou, Zhejiang, China

Kind Pharmaceutical is a clinical-stage biopharmaceutical company that focuses on the discovery and development of anemia drugs.

BiopharmaBiotechnologyHealth CareTherapeutics
Series CNov 12, 2025
Amount Raised: $56,207,405

Find More Investors Like Gaorong Capital

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides